Thierry Chignon

Chairman at

AirInSpace SE

61 year

93 connections

Health Technology

Finance

Process Industries

Profile

Thierry Chignon - Managing Partner Thierry Chignon has over 30 years of experience in Production, Quality Assurance, Quality Control, Regulatory Affairs, Clinical Trials with particular focus on the medical device sector, including a first experience as Head Pharmacist with Institut Mérieux (10 years, now Sanofi Pasteur).
As Managing Director with Quintiles Consulting Europe (now IQVIA), between 1997 and 2006, he defined and participated in the implementation of business development strategies for innovative products in Europe.
Thierry also worked for 5 years as an expert of the Commission of the European Union preparing Guidelines and Regulations for medical devices.
In 2006, Thierry joined Matignon Investissement to raise and deploy the first French fund dedicated to European medical technologies (Matignon Technologies II, €80M), including oversight of 8 investments (50% Growth Capital, 50% Venture Capital).
Thierry joined Mérieux Equity Partners in 2014, as Senior Partner, to launch and manage Mérieux Participations 2 (€150M), then Mérieux Participations 3 (€377M) with several investments in Capital Development and Buyout.
Thierry holds a Degree in Pharmacy, a Master Degree from IEP Paris (Sciences Politiques) and an executive MBA from HEC Paris.

Thierry Chignon active positions

Companies	Position	Start
AirInSpace SE AirInSpace SE Chemicals: SpecialtyProcess Industries Designs and develops air treatment solutions and equipment	Chairman	23/11/2012
Mérieux Equity Partners SAS Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners (MxEP) invests in small and mid-size companies located in Europe and North. The firm focuses on healthcare, nutrition and life sciences sectors. It participates in early stages capital requirements and growth capital transactions. The firm acquires either minority or majority stakes in its portfolio companies.	Private Equity Investor	01/05/2014
Seqens SAS Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics	Director/Board Member	-

All active positions of Thierry Chignon

Former positions of Thierry Chignon

Companies	Position	End
SUPERSONIC IMAGINE	Director/Board Member	01/08/2019
Matignon Investissement et Gestion SAS Matignon Investissement et Gestion SAS Investment ManagersFinance MIG is an active private equity investment manager with a long-term outlook. Originally investing across a variety of industries, the firm has progressively focused on sectors including medical technology, healthcare-related services and biotechnology. They also invest in the information and communication technology sector, and their expansion financing and LBO activities are not sector-specific. MIG acquires significant minority stakes in French, European and US companies, balancing their investments across development stages. The firm targets companies based on a coherent commercial strategy and whose research efforts are mature. They seek board representation. Their exit strategies favor trade sales to large biomedical groups. MIG's specific interests within their sectors of expertise have included orthopedic implants for spinal surgery, nutritional counseling, biodegradable cardiovascular stents, surgical navigation systems, glucose measurement, sleep apnea and HIV non-progression.	Private Equity Investor	14/06/2014
NANOBIOTIX	Director/Board Member	-
Medicrea SA Medicrea SA Medical SpecialtiesHealth Technology Manufactures medical prostheses for vertebral implants	Director/Board Member	-
KLEA HOLDING	Director/Board Member	-

See the detail of Thierry Chignon's experience

Training of Thierry Chignon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thierry Chignon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Matignon Investissement et Gestion SAS Matignon Investissement et Gestion SAS Investment ManagersFinance MIG is an active private equity investment manager with a long-term outlook. Originally investing across a variety of industries, the firm has progressively focused on sectors including medical technology, healthcare-related services and biotechnology. They also invest in the information and communication technology sector, and their expansion financing and LBO activities are not sector-specific. MIG acquires significant minority stakes in French, European and US companies, balancing their investments across development stages. The firm targets companies based on a coherent commercial strategy and whose research efforts are mature. They seek board representation. Their exit strategies favor trade sales to large biomedical groups. MIG's specific interests within their sectors of expertise have included orthopedic implants for spinal surgery, nutritional counseling, biodegradable cardiovascular stents, surgical navigation systems, glucose measurement, sleep apnea and HIV non-progression.	Finance
Medicrea SA Medicrea SA Medical SpecialtiesHealth Technology Manufactures medical prostheses for vertebral implants	Health Technology
AirInSpace SE AirInSpace SE Chemicals: SpecialtyProcess Industries Designs and develops air treatment solutions and equipment	Process Industries
Sciences Po Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SuperSonic Imagine SA SuperSonic Imagine SA Medical SpecialtiesHealth Technology Develops and manufactures ultrasound systems & medical imaging devices	Health Technology
École des Hautes Études Commerciales de Paris École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Seqens SAS Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics	Process Industries
Arterial Remodelling Technologies SA Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Develops bioresorbable peripheral and coronary polymer stents	Health Technology
Nanobiotix SA Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer	Health Technology
Klea Holding Klea Holding Medical SpecialtiesHealth Technology Manufactures and markets healthcare medical devices	Health Technology
Mérieux Equity Partners SAS Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners (MxEP) invests in small and mid-size companies located in Europe and North. The firm focuses on healthcare, nutrition and life sciences sectors. It participates in early stages capital requirements and growth capital transactions. The firm acquires either minority or majority stakes in its portfolio companies.	Finance